{Reference Type}: Clinical Trial, Phase I
{Title}: Safety, pharmacokinetics and efficacy of selumetinib in Chinese adult and paediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas: The primary analysis of a phase 1 open-label study.
{Author}: Wang Z;Zhang X;Li C;Liu Y;Ge X;Zhao J;Yuan X;Li Q;
{Journal}: Clin Transl Med
{Volume}: 14
{Issue}: 3
{Year}: 2024 03
{Factor}: 8.554
{DOI}: 10.1002/ctm2.1589